Skip to main content

Table 5 Response to abnormal clinical findings

From: Delivery of maternal health care in Indigenous primary care services: baseline data for an ongoing quality improvement initiative

 

NT Top End

NT Central Australia

Far West NSW

WA

North QLD

Total

No. of health centres | client records

13 | 136

2 | 45

6 | 103

9 | 193

4 | 58

34 | 535

Record of abnormal BMI (< 20 or > 30)

3% (4/136)

20% (9/45)

2% (2/103)

6% (12/193)

5% (3/58)

6% (30/535)*

   Documented plan of management

0% (0/4)

44% (4/9)

0% (0/2)

0% (0/12)

0% (0/3)

13% (4/30)*

Record of abnormal BP (≥140/90) prior to 28 weeks

1% (2/136)

11% (5/45)

1% (1/103)

0% (0/193)

0% (0/58)

2% (8/535)*

   Follow up BP done

100% (2/2)

60% (3/5)

100% (1/1)

n/a

n/a

75% (6/8)

   Urine tested for protein

100% (2/2)

60% (3/5)

100% (1/1)

n/a

n/a

75% (6/8)

   GP/Obstetric referral

50% (1/2)

80% (4/5)

100% (1/1)

n/a

n/a

75% (6/8)

   Examination by GP/Obstetrician

50% (1/2)

80% (4/5)

100% (1/1)

n/a

n/a

75% (6/8)

   Anti-hypertensive medication prescribed

50% (1/2)

20% (1/5)

100% (1/1)

n/a

n/a

38% (3/8)

Record of abnormal BP (≥140/90) at or after 28 weeks

1% (1/136)

13% (6/45)

5% (5/103)

3% (6/193)

0% (0/58)

3% (18/535)*

   Follow up BP done

100% (1/1)

100% (6/6)

60% (3/5)

50% (3/6)

n/a

72% (13/18)

   Urine tested for protein

100% (1/1)

100% (6/6)

60% (3/5)

50% (3/6)

n/a

72% (13/18)

   GP/Obstetric referral

100% (1/1)

100% (6/6)

60% (3/5)

50% (3/6)

n/a

72% (13/18)

   Examination by GP/Obstetrician

100% (1/1)

100% (6/6)

100% (5/5)

50% (3/6)

n/a

83% (15/18)

   Anti-hypertensive medication prescribed

100% (1/1)

33% (2/6)

0% (0/5)

17% (1/6)

n/a

22% (4/18)

Record of abnormal standard glucose challenge test

17% (23/136)

22% (10/45)

10% (10/103)

4% (7/193)

17% (10/58)

11% (60/535)*

   GTT undertaken

87% (20/23)

90% (9/10)

80% (8/10)

43% (3/7)

60% (6/10)

77% (46/60)

Rhesus negative

1% (1/136)

0% (0/45)

7% (7/103)

4% (8/193)

3% (2/58)

3% (18/535)*

   Anti-D injection given 26-28 wks

100% (1/1)

n/a

43% (3/7)

63% (5/8)

0% (0/2)

50% (9/18)

   Anti-D injection given 34-36 wks

100% (1/1)

n/a

29% (2/7)

63% (5/8)

0% (0/2)

40% (8/18)

Baby Rhesus positive

0% (0/136)

33% (15/45)

2% (2/103)

1% (2/193)

0% (0/58)

4% (19/535)*

   Mother given anti-D postnatal

n/a

0% (0/15)

100% (2/2)

100% (2/2)

n/a

21% (4/19)*

Anaemia (Hb < 100 g/L)

14% (19/136)

22% (10/45)

11% (11/103)

12% (24/193)

3% (2/58)

12% (66/535)*

   Iron prescribed

84% (16/19)

100%(10/10)

91% (10/11)

75% (18/24)

50% (1/2)

83% (55/66)

   Follow up FBE or Hb test done

42% (8/19)

90% (9/10)

36% (4/11)

46% (11/24)

50% (1/2)

50% (33/66)

Nitrites detected by dip stick

21% (28/136)

33% (15/45)

5% (5/103)

24% (46/193)

10% (6/58)

19% (100/535)*

   Urine sent for MSU

96% (27/28)

100%(15/15)

100% (5/5)

93% (43/46)

100% (6/6)

96% (96/100)

   Oral antibiotic prescribed

93% (26/28)

60% (9/15)

80% (4/5)

37% (17/46)

83% (5/6)

61% (61/100)*

   Record of a normal follow up MSU

46% (13/28)

100%(15/15)

40% (2/5)

26% (12/46)

83% (5/6)

47% (47/100)*

Rubella antibodies negative or low titre

35% (47/136)

7% (3/45)

15% (15/103)

15% (28/193)

7% (4/58)

18% (97/535)*

   Rubella immunisation given postnatally

36% (17/47)

67% (2/3)

13% (2/15)

32% (9/28)

0% (0/4)

31% (30/97)

  1. BP = blood pressure, BMI = body mass index, FBE = full blood examination, GP = general practitioner, GTT = glucose tolerance test, Hb = haemoglobin, MSU = midstream urine, n/a = not applicable.
  2. * P < 0.05 for comparisons between regions.